Cargando…
Blood Flow Deficits and Cerebrovascular Changes in a Dietary Model of Hyperhomocysteinemia
Elevated homocysteine in the blood, or hyperhomocysteinemia, is a recognized risk factor for multiple causes of dementia including Alzheimer’s disease. While reduction of homocysteine levels can generally be accomplished in a straightforward manner, the evidence regarding the cognitive benefits of t...
Autores principales: | Braun, David J., Abner, Erin, Bakshi, Vikas, Goulding, Danielle S., Grau, Elizabeth M., Lin, Ai-Ling, Norris, Christopher M., Sudduth, Tiffany L., Webster, Scott J., Wilcock, Donna M., Van Eldik, Linda J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668175/ https://www.ncbi.nlm.nih.gov/pubmed/31362539 http://dx.doi.org/10.1177/1759091419865788 |
Ejemplares similares
-
Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes
por: Weekman, Erica M., et al.
Publicado: (2023) -
Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain
por: Weekman, Erica M., et al.
Publicado: (2017) -
β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
por: Sudduth, Tiffany L, et al.
Publicado: (2014) -
Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue
por: Weekman, Erica M., et al.
Publicado: (2022) -
Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events
por: Weekman, Erica M., et al.
Publicado: (2019)